GeneMedicine's IGF-1 for muscular disorders to enter Phase I trials by end of 1996 -- Alex. Brown.
Executive Summary
GENEMEDICINE IGF-1 FOR MUSCULAR DISORDERS TO ENTER PHASE I trials by the end of the year, the company told the annual Alex. Brown health care seminar in Baltimore in May. The Woodlands, Tex.-based Genemedicine expects to file an IND application for insulin-like growth factor this summer.